Strasburg’s doctor: there are no studies supporting the Nats decision to shut him down

104 Comments

UPDATE II:  Yocum walks it back. Now he says he did talk to the Nats. Oy.

UPDATE: Boras says, nope, the Nats DID talk to Yocum. This is getting interesting.

12:33PM: All throughout the Strasburg Shutdown drama, we repeatedly heard how the doctors were all saying that it’s advisable to shut Strasburg down. That doctors were consulted and that the Nats’ plan was medically sound. Those of us who didn’t like the decision were told that we had to defer to the team and their cadre of medical experts because we, after all, are not doctors.

Only one problem: no one with the Nationals ever asked the guy who performed Strasburg’s surgery what he thought about it and, more significantly, the guy who performed the surgery tells the L.A. Times today that there are no studies supporting the proposition that shutting him down will protect him at all:

The doctor who performed elbow surgery on Stephen Strasburg said he did not tell the Washington Nationals to shut down their ace pitcher.

“I wasn’t asked,” Dr. Lewis Yocum told the Los Angeles Times … Yocum said that, had he been asked, he would not have been able to provide conclusive information about whether Strasburg’s long-term health would be best served by shutting him down.

“There’s no statistic as far as studies,” Yocum said.

Yocum further notes that it’s GM Mike Rizzo who came up with the 160 inning shutdown standard himself. That he imposed it in the case of Jordan Zimmermann, and that he’s doing the same with Strasburg without the aide of any medical directive.

Which, hey, that’s OK in and of itself. Zimmermann has worked out so far, so maybe Rizzo has stumbled upon a bold and effective new standard here. And it is his team and he can do what he wants and what he thinks is best for it.

But given the lack of studies on the matter, those people supporting the shutdown decision have to give up shaming those of us who don’t into silence with some notion that medical necessity or insight governed this decision.  End the erroneous appeals to medical authority — like Scott Boras has done repeatedly — and own up to the fact that it’s Mike Rizzo, not medical science, making this call.

Marlins option Tom Koehler to Triple-A, recall Hunter Cervenka

Mike Ehrmann/Getty Images
Leave a comment

Long-time rotation mainstay Tom Koehler was optioned to Triple-A New Orleans on Monday and reliever Hunter Cervenka was recalled, the Marlins announced.

Koehler, 31, made 131 starts out of the Marlins’ rotation over the last five years, but his 12 this season have not been good, so the club hopes he can figure things out with a stint in the minors. He’s carrying a 7.92 ERA with a 44/29 K/BB ratio in 55 2/3 innings. Koehler battled bursitis in his right shoulder in May and June, which may partially explain his struggles.

Cervenka, 27, posted a 4.50 ERA with a 34/21 K/BB ratio in 34 innings of relief with New Orleans. He hasn’t pitched in the majors yet this season, but compiled a 3.53 ERA over 43 1/3 innings in the bigs last year in the Marlins’ bullpen.

Nationals, Dodgers, and Red Sox are interested in Pat Neshek

Getty Images
2 Comments

At the trade deadline, relief pitching is the name of the game and one of the names clearly available is Pat Neshek. Today Mark Feinsand of MLB.com reports that the Nationals, Dodgers, and Red Sox are among the clubs who are closely scouting the Phillies reliever. Last week Ken Rosenthal reported that the Brewers and Rays were involved as well.

Neshek is an impending free agent, so he may come cheaper than Justin Wilson or some of the other bullpen arms available right now. The All-Star is 36 and is posting a fantastic season, featuring a 1.12 ERA and 45/5 K/BB ratio over 40.1 innings this season.